IDS-NO-003 |
NIH 10323 |
NSC-19045 |
OPANA |
OXYMORPHONE |
NUMORPHAN |
OXYMORPHONE CII |
OXYMORPHONE HYDROCHLORIDE |
OXIMORPHONUM |
OXYMORPHINE |
OPANA® |
14-HYDROXYDIHYDROMORPHINONE |
DIHYDROHYDROXYMORPHINONE |
EN3202 |
DIHYDROXYMORPHINONE |
chemidplus:76-41-5 |
pubchem.compound:5284604 |
rxcui:7814 |
chembl:CHEMBL963 |
drugbank:01192 |
Drug Class | adjuvants, anesthesia |
Year of Approval | approved before 1982 |
Drug Class | analgesics, opioid |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | analgesic |
antagonist (inhibitory) |
Trial Name | oxymorphone hydrochloride, EN3202,Opana, Opana ER |
Novel drug target | Established target |
OXYMORPHONE | Primary Drug Name |
Drug Class | analgesics, opioid |
Year of Approval | approved before 1982 |
Drug Class | adjuvants, anesthesia |
Drug Indications | analgesic |
Drug Class | Small Molecule |
FDA Approval | approved |
CHEMBL963 | ChEMBL Drug ID |
D02NSF | TTD Drug ID |